German G-BA looks to Bronner for the long-term
This article was originally published in Clinica
Executive Summary
Dorothea Bronner, the chief executive at the German joint federal committee (G-BA), has been reappointed to the post for a five-year period from January 2007 until the end of 2011. Dr Bonner was also head of the forerunner of the G-BA, the co-ordination committee working group. The G-BA decides on the reimbursement of healthcare products in Germany. The reinstated head has pledged to make transparency of the G-BA's work and decision-making a priority. The G-BA oversees IQWIG, its executive arm, which carries out the HTA function.
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.